Evidence map›Paper›PMID 37173535›Full record

Trial reportAnnals of hematology2023

A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients.

Qian Zhang, Mei-Juan Huang, Han-Yu Wang, Yong Wu, Yuan-Zhong Chen

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Annals of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qian ZhangFujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
Mei-Juan HuangFujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
Han-Yu WangDepartment of Cardiac Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Yong WuFujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China. wuyong9195@126.com.
Yuan-Zhong ChenFujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China. chenyz@fjmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cure rate of acute lymphoblastic leukemia (ALL) in adolescents and adults remains poor. This study aimed to establish a prognostic model for ≥14-year-old patients with ALL to guide treatment decisions. We retrospectively analyzed the data of 321 ALL patients between January 2017 and June 2020. Patients were randomly (2:1 ratio) divided into either the training or validation set. A nomogram was used to construct a prognostic model. Multivariate Cox analysis of the training set showed that age > 50 years, white blood cell count > 28.52×10

Indexed as

NomogramsPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultHumansMiddle AgedPrognosisProgression-Free SurvivalRetrospective StudiesAcute lymphoblastic leukemiaNomogramPrognosisRisk stratificationTreatment

Identifiers

PMID37173535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.